Federal grants
Grants.gov index · last synced Oct 3 at 9:01 AM
948 open618 forecasted
1,566 grants
Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
Closes Nov 5, 2027National Institutes of Health
GrantALN 93.847PAS-25-073 · Posted Jan 8, 2025Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Closes Nov 5, 2027National Institutes of Health
GrantALN 93.866Up to $1,500,000PAR-25-297 · Posted Dec 4, 2024Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)
Closes Nov 5, 2027National Institutes of Health
GrantALN 93.853PAR-25-149 · Posted Oct 28, 2024BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
Closes Nov 8, 2027National Institutes of Health
GrantALN 93.213RFA-DA-27-004 · Posted Sep 16, 2025Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)
Closes Nov 12, 2027National Institutes of Health
GrantALN 93.853PAR-25-215 · Posted Dec 2, 2024Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)
Closes Nov 12, 2027National Institutes of Health
GrantALN 93.853PAR-25-216 · Posted Dec 2, 2024NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)
Closes Nov 12, 2027National Institutes of Health
GrantALN 93.866PAR-24-321 · Posted Nov 6, 2024Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)
Closes Nov 15, 2027National Institutes of Health
GrantALN 93.865Up to $6,250,000PAR-25-311 · Posted Dec 16, 2024Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)
Closes Nov 15, 2027National Institutes of Health
GrantALN 93.395PAR-25-336 · Posted Dec 16, 2024Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)
Closes Nov 16, 2027National Institutes of Health
GrantALN 93.121Up to $100,000PAR-25-122 · Posted Oct 28, 2024Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
Closes Nov 16, 2027National Institutes of Health
GrantALN 93.865Up to $200,000PAR-25-266 · Posted Dec 2, 2024Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
Closes Nov 16, 2027National Institutes of Health
GrantALN 93.847PAR-25-068 · Posted Jan 8, 2025Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
Closes Nov 16, 2027National Institutes of Health
GrantALN 93.393PAR-25-244 · Posted Nov 18, 2024Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
Closes Nov 16, 2027National Institutes of Health
GrantALN 93.865PAR-25-265 · Posted Dec 2, 2024Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
Closes Nov 18, 2027National Institutes of Health
GrantALN 93.839Up to $300,000RFA-DA-26-034 · Posted Nov 20, 2024DEVCOM ARMY RESEARCH LABORATORY BROAD AGENCY ANNOUNCEMENT FOR FOUNDATIONAL RESEARCH
Closes Nov 20, 2027Dept of the Army -- Materiel Command
GrantALN 12.431W911NF-23-S-0001 · Posted Nov 21, 2022Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
Closes Dec 3, 2027National Institutes of Health
GrantALN 93.273RFA-DA-26-056 · Posted Dec 5, 2024Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
Closes Dec 3, 2027National Institutes of Health
GrantALN 93.273RFA-DA-26-055 · Posted Dec 5, 2024Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
Closes Dec 23, 2027National Institutes of Health
GrantALN 93.855RFA-HL-26-018 · Posted Nov 22, 2024Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
Closes Dec 23, 2027National Institutes of Health
GrantALN 93.839Up to $350,000RFA-HL-26-016 · Posted Nov 22, 2024Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
Closes Dec 23, 2027National Institutes of Health
GrantALN 93.838RFA-HL-26-017 · Posted Nov 22, 2024Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)
Closes Dec 23, 2027National Institutes of Health
GrantALN 93.837RFA-HL-26-019 · Posted Nov 22, 2024Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)
Closes Dec 23, 2027National Institutes of Health
GrantALN 93.839RFA-HL-26-020 · Posted Nov 22, 2024NPS Cooperative Ecosystems Studies Units (CESU) Master Cooperative Agreements
Closes Dec 31, 2027National Park Service
GrantALN 15.945Up to $0P23AS00132 · Posted Dec 22, 2022DEVCOM ANALYSIS CENTER BROAD AGENCY ANNOUNCEMENT FOR APPLIED RESEARCH
Closes Jan 4, 2028Dept of the Army -- Materiel Command
GrantALN 12.431W911NF-23-S-0003 · Posted Jan 5, 2023